Granules India announced that the USA Food & Drug Administration (USFDA) has authorized its Abbreviated New Drug Application (ANDA) for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg and 40 mg. It is bioequivalent and therapeutically equivalent to the reference indexed drug (RLD), Nexium Delayed-Release Capsules, 20 mg and forty mg, of AstraZeneca Pharmaceuticals LP.
Bazaarinformation team has many years of experience, covering the physical and future commodities markets with prominent commodity & equity trading advising which shines further with extensive network to get research from ground levels to generate proper reporting and movements. We are able to get evens out of odds in volatile markets and stockings. ...
